Poland· PL-100152830
Zioła przeciwreumatyczne
A medicinal product containing species antirheumaticae, registered in Poland by Labofarm sp. z o.o..
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Species antirheumaticae
- Manufacturer
- Labofarm sp. z o.o.
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990021963
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f4827faa-3563-4ffe-8134-56fbbb1b6c37 GET /v1/drugs/f4827faa-3563-4ffe-8134-56fbbb1b6c37?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Zioła do zaparzania w saszetkach",
"source": "urpl",
"strength": "-",
"packaging": "05909990021963 ¦ OTC ¦ 48305\n30 sasz. 2,3 g",
"substance": "Salicis cortex 25 g + Taraxaci radix 5 g + Populi folium 15 g + Equiseti herba 15 g + Betulae folium 15 g + Taraxaci herba 5 g + Urticae folium 20 g",
"common_name": "Species antirheumaticae",
"pl_product_id": "100152830",
"pozwolenie_nr": "IL-5996/LN",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about species antirheumaticae.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.